The Effect of Coronavirus (COVID-19) on Breast Cancer Teamwork: A Multicentric Survey.


Journal

In vivo (Athens, Greece)
ISSN: 1791-7549
Titre abrégé: In Vivo
Pays: Greece
ID NLM: 8806809

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 21 05 2020
revised: 25 05 2020
accepted: 26 05 2020
entrez: 7 6 2020
pubmed: 7 6 2020
medline: 23 6 2020
Statut: ppublish

Résumé

Despite the large amount of clinical data available of Coronavirus-19 (COVID-19), not many studies have been conducted about the psychological toll on Health Care Workers (HCWs). In this multicentric descriptive study, surveys were distributed among 4 different Breast Cancer Centers (BCC). BCCs were distinguished according to COVID-19 tertiary care hospital (COVID/No-COVID) and district prevalence (DP) (High vs. Low). DASS-21 score, PSS score and demographic data (age, sex, work) were evaluated. A total of 51 HCWs were analyzed in the study. Age, work and sex did not demonstrate statistically significant values. Statistically significant distribution was found between DASS-21-stress score and COVID/No-COVID (p=0.043). No difference was found in the remaining DASS-21 and PSS scores, dividing the HCWs according to COVID-19-hospital and DP. Working in a COVID-19-hospital represents a factor that negatively affects psychosocial well-being. However, DP seems not to affect the psychosocial well-being of BCC HCWs. During the outbreak, psychological support for low risk HCWs should be provided regardless DP.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
Despite the large amount of clinical data available of Coronavirus-19 (COVID-19), not many studies have been conducted about the psychological toll on Health Care Workers (HCWs).
PATIENTS AND METHODS METHODS
In this multicentric descriptive study, surveys were distributed among 4 different Breast Cancer Centers (BCC). BCCs were distinguished according to COVID-19 tertiary care hospital (COVID/No-COVID) and district prevalence (DP) (High vs. Low). DASS-21 score, PSS score and demographic data (age, sex, work) were evaluated.
RESULTS RESULTS
A total of 51 HCWs were analyzed in the study. Age, work and sex did not demonstrate statistically significant values. Statistically significant distribution was found between DASS-21-stress score and COVID/No-COVID (p=0.043). No difference was found in the remaining DASS-21 and PSS scores, dividing the HCWs according to COVID-19-hospital and DP.
CONCLUSION CONCLUSIONS
Working in a COVID-19-hospital represents a factor that negatively affects psychosocial well-being. However, DP seems not to affect the psychosocial well-being of BCC HCWs. During the outbreak, psychological support for low risk HCWs should be provided regardless DP.

Identifiants

pubmed: 32503830
pii: 34/3_suppl/1685
doi: 10.21873/invivo.11962
pmc: PMC8378028
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1685-1694

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Références

Front Psychol. 2020 Apr 15;11:741
pubmed: 32351436
Eur Rev Med Pharmacol Sci. 2017 Mar;21(6):1341-1345
pubmed: 28387892
J Health Soc Behav. 1983 Dec;24(4):385-96
pubmed: 6668417
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):288-291
pubmed: 32100979
Am J Surg Pathol. 2006 Nov;30(11):1445-53
pubmed: 17063087
Anticancer Res. 2020 Jan;40(1):281-286
pubmed: 31892577
BMJ. 2012 Apr 26;344:e2718
pubmed: 22539013
Int J Breast Cancer. 2014;2014:469803
pubmed: 24672730
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
J Travel Med. 2020 May 18;27(3):
pubmed: 32181488
CMAJ. 2004 Mar 2;170(5):793-8
pubmed: 14993174
Can J Anaesth. 2020 Jun;67(6):732-745
pubmed: 32162212
N Engl J Med. 2020 May 14;382(20):1873-1875
pubmed: 32187459
Psychosom Med. 2004 Nov-Dec;66(6):938-42
pubmed: 15564361
Int J Mol Sci. 2017 Jul 07;18(7):
pubmed: 28686211
Updates Surg. 2020 Jun;72(2):537-546
pubmed: 32062785
J Infect Dev Ctries. 2020 Feb 29;14(2):125-128
pubmed: 32146445
World J Surg. 2019 Mar;43(3):839-845
pubmed: 30456482
Front Oncol. 2020 May 22;10:938
pubmed: 32574281
In Vivo. 2020 Jun;34(3 Suppl):1651-1659
pubmed: 32503825
In Vivo. 2020 Jun;34(3 Suppl):1661-1665
pubmed: 32503826
JAMA. 2007 Oct 10;298(14):1685-7
pubmed: 17925521
In Vivo. 2019 Nov-Dec;33(6):1879-1884
pubmed: 31662515
Ann Thorac Surg. 2010 Sep;90(3):973-8
pubmed: 20732526
J Psychosom Res. 2008 Feb;64(2):177-83
pubmed: 18222131
J Pers Soc Psychol. 1993 Jan;64(1):131-40
pubmed: 8421249
Ann Surg Oncol. 2003 Jul;10(6):606-15
pubmed: 12839844
PLoS One. 2017 Sep 18;12(9):e0184680
pubmed: 28922402
Breast. 2017 Aug;34 Suppl 1:S82-S84
pubmed: 28673535
Anticancer Res. 2018 Apr;38(4):2109-2117
pubmed: 29599329
Eur J Cancer. 2013 Nov;49(17):3579-87
pubmed: 23968730
Breast Care (Basel). 2019 Dec;14(6):359-365
pubmed: 31933581
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Eur Rev Med Pharmacol Sci. 2016 Jul;20(14):2950-4
pubmed: 27460720
Eur J Surg Oncol. 2017 Feb;43(2):303-310
pubmed: 28069398
BMC Infect Dis. 2010 Nov 09;10:322
pubmed: 21062471

Auteurs

Gianluca Vanni (G)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Marco Materazzo (M)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy mrcmaterazzo@gmail.com.

Francesca Santori (F)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Marco Pellicciaro (M)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Maria Costesta (M)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Paolo Orsaria (P)

Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.

Francesca Cattadori (F)

UO Breast Surgery, Breast Unit, "Guglielmo da Saliceto" Hospital, Piacenza, Italy.

Chiara Adriana Pistolese (CA)

Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy.

Tommaso Perretta (T)

Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy.

Marcello Chiocchi (M)

Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy.

Rosaria Meucci (R)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.
Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy.

Feliciana Lamacchia (F)

Department of Diagnostic Imaging and Interventional Radiology, Molecular Imaging and Radiotherapy, Policlinico Tor Vergata University, Rome, Italy.

Massimo Assogna (M)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Jonathan Caspi (J)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Alessandra Vittoria Granai (AV)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Adriano DE Majo (A)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Agostino Chiaravalloti (A)

Department of Biomedicine and Prevention, Policlinico Tor Vergata University, Rome, Italy.
IRCCS Neuromed, UOC Medicina Nucleare, Pozzilli, Italy.

Maria Rolando D'Angelillo (MR)

Radiotherapy Unit, Department of Oncology and Hematology, Policlinico Tor Vergata University, Rome, Italy.

Rosaria Barbarino (R)

Radiotherapy Unit, Department of Oncology and Hematology, Policlinico Tor Vergata University, Rome, Italy.

Sara Ingallinella (S)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Ljuba Morando (L)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Stefania Dalli (S)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Ilaria Portarena (I)

Department of Oncology, Policlinico Tor Vergata University, Rome, Italy.

Vittorio Altomare (V)

Department of Breast Surgery, University Campus Bio-Medico, Rome, Italy.

Giovanni Tazzioli (G)

Oncologic Breast Surgery Unit, Azienda Ospedaliero-Universitaria Policlinico Hospital of Modena, Modena, Italy.

Oreste Claudio Buonomo (OC)

Breast Unit, Department of Surgical Science, Policlinico Tor Vergata University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH